StockNews.AI
IRTC
StockNews.AI
53 days

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

1. iRhythm received an FDA Warning Letter for quality compliance issues. 2. The FDA cited risks related to the Zio AT device’s marketing practices. 3. iRhythm faces a class action lawsuit over undisclosed material information. 4. The court has denied the company's motion to dismiss the lawsuit. 5. KSF is investigating potential breaches of fiduciary duties by iRhythm's executives.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The FDA warning and ongoing lawsuits create significant risk, similar to past cases like Theranos, which faced severe financial and reputational damage due to similar issues.

How important is it?

The legal challenges and regulatory scrutiny are likely to lead to immediate stock price volatility and investor concern.

Why Short Term?

Immediate investor sentiment may deteriorate due to legal and regulatory challenges, affecting stock performance.

Related Companies

IRTC
- NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into iRhythm Technologies, Inc. (NasdaqGS: IRTC). On May 30, 2023, the Company disclosed the receipt of a Warning Letter from the FDA regarding “non-conformities to regulations for medical devices, including medical device reporting requirements, relating to the Company’s Zio AT System and medical device quality system requirements,” specifically addressing a series of deficiencies tied to the marketing and capabilities of the Zio AT device that potentially posed a known but undisclosed risk to patients, for example transmission limits of arrhythmia or heart irregularity events. Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws. Recently, the court denied the Company’s motion to dismiss the case in part, allowing the case to continue. KSF’s investigation is focusing on whether iRhythm’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws. If you have information that would assist KSF in its investigation, or have been a long-term holder of iRhythm shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-irtc/ to learn more. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg. TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services To learn more about KSF, you may visit www.ksfcounsel.com. CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn More News From Kahn Swick & Foti, LLC

Related News